Avastin is no longer FDA approved for breast cancer. This decision was upheld at a hearing last week. Eye patients, however, need not worry.
The Food and Drug Administration had removed its approval for Avastin for the treatment of breast cancer last December. A hearing last week (June, 2011) allowed Genentech and the drugs’ supporters, to voice their concerns about the removal of the drug.
- While the FDA has removed its (Read more...)